Welcome to JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES) May 24, 2025
MA Ying, PENG Zhi-lan, CHEN Xin, et al. The Regulation Mechanism of MASPIN Expression in Ovarian Carcinoma[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(1): 15-20.
Citation: MA Ying, PENG Zhi-lan, CHEN Xin, et al. The Regulation Mechanism of MASPIN Expression in Ovarian Carcinoma[J]. Journal of Sichuan University (Medical Sciences), 2013, 44(1): 15-20.

The Regulation Mechanism of MASPIN Expression in Ovarian Carcinoma

More Information
  • Received Date: July 12, 2012
  • Revised Date: October 29, 2012
  • Published Date: January 19, 2013
  • Objective To study the regulation of P63 on expression of MASPIN in ovarian cancer by observe MASPIN promoter activity changes before and after transient transfection of constructed P63 and MASPIN reporter gene plasmids. Methods The MASPIN reporter plasmid, fused with luciferase reporter gene, was constructed and transfected into SKOV3 cells together with P63 (TAP63, ΔNP63) express plasmid transiently. The MASPIN promoter activity was determined in both the transfected cells and controlled ones by Luciferase Assays and the transcription of MASPIN mRNA of them was evaluated with semi quantitative RT-PCR. Results The MASPIN reporter plasmid was successfully constructed and transiently transfected into SKOV3 cells together with P63 (TAP63, ΔNP63) expression plasmid. The data showed among the tested P63 splice variants, TAP63 remarkably activated MASPIN promoter transactivation (P<0.05). No significant difference in the activity level of MASPIN promoter was detected in the SKOV3-vector and SKOV3-ΔNP63 cells (P>0.05). The level of MASPIN mRNA expression was notably enhanced in SKOV3-TAP63 cell after transient transfected with TAP63 express plasmid (P<0.05), but no significant difference among the SKOV3, SKOV3-vector and SKOV3-ΔNP63 cell(P>0.05)was detected. Conclusion TAP63 can activate the transcription activity of MASPIN promoter, as well as regulate the expression of MASPIN. Put all together, these results suggested that MASPIN is a new molecular target of P63.
  • [1]
    Zou Z, Anisowicz A, Hendrix MJC, et al.Maspin,a serpin with tumor-suppressing activity in human mammary epithelial cells. Science,1994;263(5146):526-529.
    [2]
    Pemberton PA, Tipton AR,Pavloff N,et al. Maspin is an intracellular serpin that partitions into secretory esicles and is present at the cell surface. J Histochem Cytochem,1997;45(12):1697-1706.
    [3]
    Song SY,Lee SK,Kim DH,et al. Expression of maspin in colon cancers: its relationship with p53 expression and microvessel density. Dig Dis Sci,2002;47(8):1831-1835.
    [4]
    Maass N, Teffner M, Rosel F, et al. Decline in the expression of the serpin proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol,2001;195(3):321-326.
    [5]
    Sood AK, Fletcher MS, Gruman LM,et al. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res,2002;8(9):2924-2932.
    [6]
    Zou Z, Gao C, Nagaich AK,et al. P53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem,2000;275(9):6051-6054.
    [7]
    Futscher BW, Oshiro MM, Wozniak RJ, et al. Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet,2002;31(2):175-179.
    [8]
    Kim S, Han J, Kim J,et al.Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression. Cancer Res,2004;64(1):6900-6905.
    [10]
    Zhang M, Magit D,Sager R. Expression of maspin in prostate cells is regulated by a positive Ets element and a negative hormonal responsive element site recognized by androgen receptor. Proc Natl Acad Sci U S A,1997;94(11):5673-5678.
    [11]
    Sato N, Fukushima N, Matsubayashi H, et al. Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene,2004;23(8):1531-1538.
    [12]
    Oshiro MM,Watts GS,Wozniak RJ,et al.Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression. Oncogene,2003;22(23):3624-3634.
    [13]
    Umekita Y, Ohi Y, Souda M, et al.Maspin expression is frequent and correlates with basal markers in triple-negative breast cancer. Diagn Pathol,2011;6:36.
    [14]
    Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell,1998;2(3):305-316.
    [15]
    Dohn M,Zhang S,Chen X.p63alpha and dehaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.Oncogene,2001;20(25):3193-3205.
    [16]
    Naylor LH. Reporter gene technology: the futhre looks bright. Biochem Pharmacol,1999;58(5):749-757.
    [17]
    Erchuck A, Robert C. P53 based gene therapy of ovarian cancer magic bullet. J Gynecol Oncol,1995;59(2):169-171.
    [18]
    De Laurenzi V,Melino G. Evolution of funotions within the p53/p63/p73 family.Ann N Y Acad Sci,2000;926(12):90-100.

Catalog

    Article views (2980) PDF downloads (51) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return